# FDA Inspection 1251100 - Louise Taber, MD - September 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/louise-taber-md/690aa0c6-4617-4a0b-9b02-9a38e648dc0b
Source feed: FDA_Inspections

> FDA Inspection 1251100 for Louise Taber, MD on September 26, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251100
- Company Name: Louise Taber, MD
- Inspection Date: 2024-09-26
- Product Type: Human Drugs
- Office Name: Denver District Office

## Related Documents

- [FDA Inspection 1251100 - 2024-09-26](https://www.keypedia.com/records/fda_inspections/louise-taber-md/9fbd4936-d750-4681-be88-ada5340ded72)
- [FDA Inspection 971681 - 2016-05-20](https://www.keypedia.com/records/fda_inspections/louise-taber-md/21e0f686-e866-469d-8b70-a7ea59aafcf9)
- [FDA Inspection 888259 - 2014-07-18](https://www.keypedia.com/records/fda_inspections/louise-taber-md/9c1b4936-be59-4932-9b01-2f136eedb92f)

Company: https://www.keypedia.com/companies/louise-taber-md/fb11ea8d-56e5-4a35-8ba4-b462b4ccf4c1

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face